Printer Friendly

DANTE FASCELL APPOINTED TO IVAX BOARD OF DIRECTORS

 MIAMI, Feb. 23 /PRNewswire/ -- IVAX Corporation (AMEX: IVX) announced today that its board of directors appointed Dante B. Fascell as a new member of the board.
 After completing his 38th year in the United States House of Representatives, Dante B. Fascell is one of South Florida's -- and the nation's -- most distinguished legislators. He became Chairman of the House Foreign Affairs Committee in 1984 and was a member of that committee for 35 years, making him one of the most knowledgeable and influential shapers in our nation's foreign policy.
 Fascell has played a leading role in legislation providing necessary aid to Israel; placing and maintaining the trade embargo on Cuba; prohibiting discrimination in foreign commerce; supporting a nuclear freeze; changing the focus of foreign aid so that it benefits the poorest people in developing countries; providing Congress with review authority and procedure on major arms sales abroad; requiring the president to consult with Congress on actions leading to war; reorganizing and maintaining Radio Free Europe and Radio Liberty; writing comprehensive anti-terrorism legislation; restructuring and overhauling of the Foreign Service Personnel System; and reviewing the effectiveness of U.S consular services abroad. He is considered one of the leading experts on Latin American and Caribbean affairs and on international communications.
 In 1969, by appointment of the president, Fascell served as a member of the U.S. delegation to the 24th General Assembly of the United Nations, with the rank of Ambassador. In 1985 he was appointed as an official Congressional Observer to the Geneva Arms Control talks.
 During his long career of public service, he has also been known as a strong advocate for measures affecting his South Florida constituency. He is credited for being instrumental in obtaining federal support for such vital community assets as the Miami Harbor, Biscayne National Park, Everglades National Park, the Florida Keys National Marine Sanctuary, the Florida Keys' bridges, Metrozoo, the Federal Courthouse Annex, Radio Marti and funds spent on services to mass influxes of refugees.
 Fascell has been a resident of Miami since he was eight years old, a graduate of the University of Miami's School of Law and a member of the University's Board of Trustees. He is a member of the "We Will Rebuild" committee for the benefit of Hurricane Andrew victims and a leader in the rebuilding efforts of Homestead Air Force Base.
 IVAX Corporation is a holding company with subsidiaries involved in specialty chemicals, pharmaceuticals and medical diagnostics. IVAX' principal subsidiaries include Baker Norton Pharmaceuticals, Inc., a manufacturer, developer and marketer of unique brand name pharmaceuticals; Norton Healthcare Limited, a leading manufacturer and marketer of generic pharmaceuticals in the United Kingdom, Ireland and other countries; H.N. Norton Co. (formerly LuChem Pharmaceuticals, Inc.), a manufacturer of generic pharmaceuticals in the United States; Goldline Laboratories, Inc., a national marketer of generic prescription and over-the-counter pharmaceuticals in the United States; Baker Cummins Dermatologicals, Inc., a dermatological products company; Flori Roberts, Inc., a skin care and cosmetics company; DVM Pharmaceuticals Inc., a veterinary products company; Diamedix Corporation, a medical diagnostics company; Delta Biologicals S.r.l, a marketer of medical diagnostic tests and instruments in Italy; and IVAX Industries, Inc., a chemical specialties business.
 -0- 2/22/93
 /CONTACT: Richard C. Pfenniger Jr. , senior vice president-legal affairs of IVAX Corporation, 305-590-2309/
 (IVX)


CO: IVAX Corporation ST: Florida IN: MTC SU: PER

JB-AW -- FL009 -- 9441 02/23/93 13:08 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 23, 1993
Words:566
Previous Article:HOLIDAY RV SUPERSTORES, INC. REPORTS 1ST QUARTER REVENUES UP 39 PERCENT
Next Article:BARNETT NAMES REDICK DIRECTOR OF FINANCE
Topics:


Related Articles
NEW MEMBER APPOINTED TO IVAX BOARD OF DIRECTORS
IVAX ANNOUNCES APPOINTMENTS OF OFFICERS
IVAX ANNOUNCES RESULTS OF ANNUAL MEETING AND PROMOTION OF DR. JOHN K. WHISNANT
IVAX ANNOUNCES SEMI-ANNUAL DIVIDEND
IVAX JOINS FORTUNE 500; EXPANDS MANAGEMENT TEAM
IVAX ANNOUNCES KEY MANAGEMENT APPOINTMENTS AT BAKER NORTON PHARMACEUTICALS
IVAX ANNOUNCES KEY MANAGEMENT APPOINTMENTS AT BAKER NORTON PHARMACEUTICALS
IVAX CORPORATION APPOINTS DR. SAMUEL BRODER AS CHIEF SCIENTIFIC OFFICER
IVAX Corporation Appoints Robert C. Strauss as President and Chief Operating Officer
Dr. Rafick G. Henein Named President and CEO Of IVAX Subsidiary Zenith Goldline Pharmaceuticals

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters